Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -38,440 | 0 |
| Depreciation Amortization | N/A | N/A | N/A | 7,250 | 0 |
| Accounts receivable | N/A | N/A | N/A | -8,004 | N/A |
| Other Working Capital | N/A | N/A | N/A | 5,170 | 0 |
| Other Operating Activity | -32,656 | -13,312 | -1,890 | 18,694 | -15,350 |
| Operating Cash Flow | $-32,656 | $-13,312 | $-1,890 | $-15,330 | $-15,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,033 | -115,729 | -101,298 | -46,649 | N/A |
| PPE Investments | -43,035 | -30,940 | -13,583 | -20,500 | -10,390 |
| Net Acquisitions | N/A | N/A | N/A | -15,280 | 0 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -15,288 | N/A |
| Other Investing Activity | -193 | -316 | -115 | -1 | 18,820 |
| Investing Cash Flow | $-126,261 | $-146,985 | $-114,996 | $-82,430 | $8,430 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 222,439 | 222,439 | 222,439 | 104,806 | N/A |
| Debt Repayment | -28 | -27 | -18 | -64 | N/A |
| Common Stock Issued | 13,353 | 10,187 | 7,382 | 1,545 | N/A |
| Other Financing Activity | -17,182 | -16,957 | -16,569 | -7 | 1,280 |
| Financing Cash Flow | $218,582 | $215,642 | $213,234 | $106,280 | $1,280 |
| Beginning Cash Position | 33,430 | 33,430 | 33,430 | 24,910 | 24,910 |
| End Cash Position | 93,095 | 88,775 | 129,778 | 33,430 | 19,280 |
| Net Cash Flow | $59,665 | $55,345 | $96,348 | $8,510 | $-5,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,656 | -13,312 | -1,890 | -15,330 | -15,350 |
| Capital Expenditure | -43,035 | -30,940 | -13,583 | -20,502 | N/A |
| Free Cash Flow | -75,691 | -44,252 | -15,473 | -35,832 | -15,350 |